Wnt signaling enhances the activation and survival of human hepatic stellate cells  by Myung, Sun Jung et al.
FEBS Letters 581 (2007) 2954–2958Wnt signaling enhances the activation and survival of human
hepatic stellate cells
Sun Jung Myunga, Jung-Hwan Yoona,*, Geum-Youn Gwaka, Won Kima, Jeong-Hoon Leea,
Kang Mo Kima, Chan Soo Shina, Ja June Jangb, Sung-Hee Leea, Soo-Mi Leea, Hyo-Suk Leea
a Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea
b Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea
Received 25 January 2007; revised 9 May 2007; accepted 18 May 2007
Available online 29 May 2007
Edited by Veli-Pekka LehtoAbstract Wnt signaling was implicated in pulmonary and renal
ﬁbrosis. Since Wnt activity is enhanced in liver cirrhosis, Wnt
signaling may also participate in hepatic ﬁbrogenesis. Thus, we
determined if Wnt signaling modulates hepatic stellate cell
(HSC) activation and survival. Wnt3A treatment signiﬁcantly
activated human HSCs, while this was inhibited in secreted friz-
zled-related protein 1 (sFRP1) overexpressing cells. Wnt3A
treatment signiﬁcantly suppressed TRAIL-induced apoptosis in
control HSCs versus sFRP1 over-expressing cells. Particularly,
caspase 3 was more activated in sFRP1 over-expressing cells fol-
lowing TRAIL and Wnt3A treatment. These observations imply
that Wnt signaling promotes hepatic ﬁbrosis by enhancing HSC
activation and survival.
 2007 Federation of European Biochemical Societies.
Published by Elsevier B.V. All rights reserved.
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Hepatic ﬁbrosis is a common wound-healing response to
chronic liver injuries, including persistent viral infection, alco-
holic or drug toxicity and hereditary metal overload [1]. Acti-
vated hepatic stellate cells (HSCs) are the most important
source of extracellular matrix proteins during this ﬁbrotic pro-
cess [2]. Therefore, the majority of anti-ﬁbrotic therapies are
designed to inhibit the activation, proliferation, or synthetic
products of HSCs. More recently, the selective induction of
HSC apoptosis by TRAIL (tumor necrosis factor-related
apoptosis-inducing ligand) has been proposed as an anti-ﬁbro-
tic treatment [3].
Vertebrate Wnt and Drosophila wingless are homologous
genes, and their protein products have been shown to partici-
pate in the regulation of cellular diﬀerentiation, proliferation,
and polarity [4]. More recently, Wnt signaling was implicated
in human ﬁbrosing diseases, such as pulmonary and renal
ﬁbrosis [5,6]. Given that Wnt activity is enhanced in liver cir-
rhosis [7], it is also likely that Wnt signaling participates in he-
patic ﬁbrogenesis.
Secreted frizzled-related proteins (sFRPs) are soluble proteins
that are capable of binding toWnt and its receptor, frizzled (Fz),*Corresponding author. Fax: +82 2 743 6701.
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doi:10.1016/j.febslet.2007.05.050and thereby, interferewithWnt signaling [8].Diverse sFRP fam-
ily members exhibit distinctive expression patterns, and modu-
late various aspects of Wnt signaling. In particular, sFRP1
plays aprominent role in the regulationof cellular apoptosis, dif-
ferentiation, and angiogenesis [4,8]. If Wnt activation promotes
hepatic ﬁbrosis, the inhibition of this signaling by sFRP is likely
to attenuate the Wnt-dependent activation of hepatic ﬁbrosis.
In the present study, we hypothesized that Wnt signaling pro-
motes hepatic ﬁbrosis, and that the inhibition of this signaling
by sFRP attenuates the Wnt-dependent activation of hepatic
ﬁbrosis. To test this hypothesis, we formulated the following
questions: (i) Are Wnt receptors expressed in human HSCs?
(ii) DoesWnt signaling enhance the activation or anti-apoptotic
signaling of HSCs? And if so, (iii) Does sFRP inhibit theseWnt-
dependent processes in HSCs? Collectively, our results demon-
strate that Wnt signaling does participate in hepatic ﬁbrosis by
enhancing HSC activation and survival, and that this process is
eﬀectively prevented by sFRP1 over-expression, thus suggesting
that the selective interruption of this signaling pathway may
provide an eﬃcient anti-ﬁbrotic strategy in hepatic ﬁbrosis.2. Materials and methods
2.1. Cell culture and reagents
LX-2 cells, an immortalized human HSC line, were used in this
study, and were cultured in Dulbecco’s modiﬁed Eagle medium
(DMEM) supplemented with 10% fetal bovine serum, 100,000 U/L
penicillin, 100 mg/L streptomycin, and 100 nM insulin. Cells were pla-
ted at 5 · 104 cells/well in 1 mL of media or 106 cells in 5 mL of media
in 6-well plate or 100-mm culture dish, respectively. Wnt3A-condi-
tioned or control medium was prepared from a stably transfected
mouse L cell clone, which secreted soluble Wnt3A proteins into the
medium, or control L cells, respectively, as previously described with
minor modiﬁcation [9], and was diluted to a ﬁnal concentration of
30%. TRAIL was purchased from Alexis (San Diego, CA).
2.2. Isolation of HSCs from normal human liver tissues
HSCs were isolated from a normal adult liver specimen obtained dur-
ing the surgical resection of a metastatic tumor by collagenase/pronase
digestion, followed by density gradient centrifugation using Nycodenz,
as described previously [10]. The purity of the isolated HSCs, as deter-
mined by vitamin A autoﬂuorescence, was more than 97% at 24 h after
plating. The human material used in this study was a normally dis-
carded specimen, and the study protocol was approved by the Institu-
tional Review Board of Seoul National University Hospital.
2.3. Reverse transcription-polymerase chain reaction (RT-PCR)
Total RNA was extracted from cells using Trizol Reagent (Invitro-
gen, Carlsbad, CA). cDNA templates were prepared using oligo-dT
random primers and MoMLV (Moloney Murine Leukemia Virus)blished by Elsevier B.V. All rights reserved.
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the Fz genes (forward, 5 0-cagcgtcttgcccgaccagatcca; reverse, 5 0-
ctagcgccgctcttcgtgtacctg) [11]. To exclude the possibility of the pres-
ence of genomic DNA in the reaction, we performed control reactions
without the RT step. RT-PCR products were subcloned using TOPO
TA cloning kits (Invitrogen). Positive clones were sequenced using
an ABI PRISM 377 Genetic Analyzer (Applied Biosystems, San
Francisco), and genes were identiﬁed by BLAST searching.2.4. Vectors
The sFRP1 cDNA clone was a gift from Dr. Jeremy Nathans (Johns
Hopkins University, Baltimore, MD). A hemagglutinin epitope was
incorporated at the C-terminal of sFRP1 by PCR, and then ligated
into the BglII/EcoRI site of pMSCV-IRES-GFP retroviral vector (a
gift from Neil A. Clipstone, Northwestern University, Chicago, IL) up-
stream of IRES to give pMSCV-sFRP1-IRES-GFP.2.5. Retrovirus generation and transduction
For the transient generation of VSV-G pseudo-typed retrovirus,
293T cells were transfected with pMD-gag-pol, pMD-VSVG (both
gifts from Dr. Richard C. Mulligan (Harvard Medical School, Boston,
MA)) and the retroviral vectors pMSCV-sFRP1-IRES-GFP or
pMSCV-IRES-GFP using LipofectAMINE Plus reagents (Invitrogen,
Carlsbad, CA). LX-2 cells were transduced with virus-containing
supernatants in the presence of 8 lg/mL of Polybrene for 6 h and cells
were collected 48 h later. GFP-positive fractions were FACS-sorted
using a BD FACS Vantage Cell Sorter (Franklin Lakes, NJ).2.6. Reporter gene assay
Cells were cotransfected over 24 h using 20 ng TK Renilla-CMV and
0.2 lg TCF reporter plasmid (Upstate Biotechnology Inc., Lake Pla-
cid, NY). Fireﬂy and Renilla luciferase activities were quantitated
using a dual luciferase reporter assay system (Promega, Madison,
WI). Data are expressed as ratios of ﬁreﬂy to Renilla luciferase activ-
ity.
2.7. Real-time PCR
Total RNA was extracted and cDNA templates were prepared as de-
scribed above. Collagen a1 mRNA was quantitated using real-time
PCR technology and the following primers: forward, 5 0-aacatgac-
caaaaaccaaaagtg, reverse, 5 0-cattgtttcctgtgtcttctgg. Universal 18S
primers (Ambion Inc., Austin, TX) were used as a control for RNA
integrity and as a ‘‘housekeeping gene’’. For quantitation, we used
real-time PCR (LightCycler, Roche Molecular Biochemicals, Mann-
heim, Germany) and SYBR green as the ﬂuorophore (Molecular
Probes, Eugene, OR).
2.8. Apoptosis
Apoptosis was induced in LX2 cells using TRAIL [3], and assessed
by examining characteristic nuclear changes (i.e., chromatin condensa-
tion and nuclear fragmentation) using the nuclear binding dye 4 0,6-
diamidino-2-phenylindole dihydrochloride (DAPI) and ﬂuorescence
microscopy (Zeiss, Germany).
2.9. Immunoblotting
Cell lysates were resolved by SDS–PAGE, and blotted using appro-
priate primary antibodies and peroxidase-conjugated secondary anti-
bodies (Biosource International, Camarillo, CA). The primary
antibodies used were; rabbit anti-caspase 9 from Cell Signaling Tech-
nology Inc. (Beverly, MA); rabbit anti-caspase 8, mouse anti-cyto-
chrome c and rabbit anti-caspase 3 from Pharmingen (San Diego,
CA); mouse anti-a-smooth muscle actin from BioGenex (San Ramon,
CA); and rabbit anti-sFRP1 and goat anti-b-actin from Santa Cruz
Biotechnology Inc. (Santa Cruz, CA).2.10. Immunoprecipitation analysis
Cells were treated with Wnt3A-conditioned media for 24 h, and
apoptosis was induced using TRAIL. The cell lysates obtained were
mixed with anti-sera for XIAP (X chromosome-linked inhibitor of
apoptosis protein) (Cell Signaling Technology Inc.), and then incu-
bated overnight at 4 C. Immune complexes were immunoprecipitated
with protein A/G PLUS-Agarose (Santa Cruz) and then washed for5 · 10 min with 1 mL of washing buﬀer. After washing, polypeptides
were resolved by boiling with Laemmli sample buﬀer, and then immu-
noblotted for caspase 9.2.11. Statistical analysis
All numerical data represent at least three independent experiments
using cells from a minimum of three separate isolations and are ex-
pressed as means ± S.D. Groups were compared using two-tailed Stu-
dent’s t-tests.3. Results
3.1. Identiﬁcation of Wnt receptors in human HSCs
RT-PCR using primers that bind to the conserved sequences
of all Fz genes were used to visualize the expressions of these
genes in both LX-2 cells and primarily isolated human HSCs
(Fig. 1a). PCR products from LX-2 cells were cloned using
the TA cloning procedure, and random clones were analyzed
by sequencing. Six out of sixteen clones sequenced were iden-
tiﬁed as containing Fz gene sequences, such as Fz-2, Fz-7,
and Fz-10, by BLAST searching (Fig. 1b). These ﬁndings indi-
cate that human HSCs are capable of responding to a Wnt
stimulus.3.2. Establishment of a human HSC line over-expressing sFRP1
To inhibit Wnt signaling in HSCs, we established a human
HSC line over-expressing sFRP1 by infecting LX-2 cells with
an sFRP1/GFP expression vector and by the ﬂow cytometric
cloning of GFP-expressing cells. sFRP1 over-expression in
these cells was conﬁrmed by immunoblot analysis (Fig. 2a).3.3. Functional analysis of Wnt activity in human HSCs
We next evaluated whether canonical Wnt signaling is func-
tionally active in human HSCs, and whether this is inhibited in
sFRP1 over-expressing cells. For this purpose, cells were stim-
ulated using Wnt3A, which is capable of activating the canon-
ical Wnt pathway. Canonical Wnt signaling activity was
evaluated by TOPﬂash TCF-luciferase reporter gene assay.
Following Wnt3A-conditioned media treatment, a twofold in-
crease in TOPﬂash reporter gene activity was observed in con-
trol cells, whereas this was signiﬁcantly suppressed in sFRP1
over-expressing cells (Fig. 2b). These ﬁndings indicate that
the canonical Wnt signaling pathway is functionally active in
human HSCs.
3.4. Wnt regulation of HSC activation
The expressions of collagen a1 and a-smooth muscle actin
(ﬁbrosis-related markers during HSC activation) were com-
pared in control and sFRP1 over-expressing HSCs. Treatment
of control cells with Wnt3A-conditioned media for 24 h in-
creased collagen a1 mRNA levels, whereas this was not ob-
served in sFRP1 over-expressing cells (Fig. 3a). In a similar
way, a-smooth muscle actin expression was increased in con-
trol cells following Wnt3A treatment, whereas this was not evi-
dent in sFRP1 over-expressing cells (Fig. 3b). These ﬁndings
indicate canonical Wnt signaling participates in HSC activa-
tion.
3.5. Wnt signaling in HSC apoptosis
We next evaluated if Wnt signaling modulates HSC survival
by regulating cellular apoptotic processes. When cells were
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Fig. 2. Establishment of a human HSC line over-expressing sFRP1.
(a) LX-2 cells were either infected with retroviral vector pMSCV-
IRES-GFP or pMSCV-sFRP1-IRES-GFP encoding sFRP1. GFP-
expressing cells were then ﬂow cytometrically cloned. Lysates of
control and sFRP1 over-expressing cells were immunoblotted with
anti-sFRP1 and anti-b-actin antibodies. (b) Control and sFRP1 over-
expressing cells were cotransfected with TK Renilla-CMV and TCF
reporter plasmid. Cells were then treated with Wnt3A-conditioned
media (CM) for 24 h. Both ﬁreﬂy and Renilla luciferase activities were
quantitated using a dual luciferase reporter assay system. Data are
expressed as ratios of ﬁreﬂy to Renilla luciferase activity.
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Fig. 3. Wnt regulation of HSC activation. (a) Control and sFRP1
over-expressing cells were treated with Wnt3A-CM for the indicated
times. Total cellular RNA was isolated and real-time PCR was then
performed. Results are expressed as ratios of collagen a1 product
copies/mL to 18S copies/mL, assuming that of the time 0 as 1. All data
are expressed as the means ± S.D. of ﬁve individual experiments. (b)
Control and sFRP1 over-expressing cells were treated with Wnt3A-
CM for the indicated times. Cells were then lysed and immunoblot
analysis was performed for a-smooth muscle actin and b-actin.
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Fig. 1. Expression of Fz (frizzled) gene families in human HSCs. (a) Total cellular RNA was isolated from LX-2 cells and HSCs obtained from
resected human liver. Reverse transcription PCR was performed using primers speciﬁc for the Fz gene. NC, negative control. (b) RT-PCR products
of LX2 cells were subcloned and sequenced. Expressed Fz genes were identiﬁed by BLAST searching.
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suppressed cellular apoptosis in control cells versus sFRP1
over-expressing cells (Fig. 4a). As shown in Fig. 4b, TRAIL-
induced caspase 8, cytochrome c, and caspase 9 modulations
were similar in control and sFRP1 over-expressing cells,whereas caspase 3 activation was more enhanced in sFRP1
over-expressing cells than in control cells (Fig. 4b). To further
characterize the mechanism underlying enhanced caspase 3
activation in these cells, we immunoprecipitated XIAP from
cell lysates, and then immunoblotted these precipitates with
caspase 8 55KD
0        2 4        0 2        4       h
Control                 sFRP1
43KDβ-actin
15KDcytochrome c
47KD
caspase 9
caspase 3
35KD
18KD
47KD
35KD
53KD
caspase 9
TRAIL
XIAP
Control sFRP1PC
IP:XIAP
a
b
+ + +__
Fig. 4. Wnt signaling and HSC apoptosis. (a) Control and sFRP1 over-expressing cells were incubated with or without Wnt3A-CM for 24 h. Cells
were then incubated with TRAIL for 9 h. Apoptosis was quantitated by DAPI staining and ﬂuorescence microscopy. Data are expressed as the
means ± S.D. of three individual experiments. (b) Control and sFRP1 over-expressing cells were treated with Wnt3A-CM for 24 h. Cells were then
incubated with TRAIL (100 ng/mL) for the indicated times. Immunoblotting was performed using the indicated antibodies. (c) Control and sFRP1
over-expressing cells were treated with Wnt3A-conditioned media for 24 h, and then incubated with or without TRAIL (100 ng/mL) for 4 h. XIAP
was immunoprecipitated from whole cell lysates, and these precipitates were immunoblotted for caspase 9 and XIAP. PC, positive control, TRAIL-
treated whole cell lysates.
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complex formation between XIAP and active caspase 9 in con-
trol cells, whereas this was diminished in sFRP1 over-express-
ing cells. Therefore, these observations collectively indicate
that canonical Wnt signaling exerts an anti-apoptotic eﬀect
in HSCs by regulating complex formation between XIAP
and caspase 9, thus enhancing HSC survival.4. Discussion
The principal ﬁnding of this study relates to Wnt signaling
during hepatic ﬁbrosis. Our results collectively demonstrate
that Wnt signaling participates in hepatic ﬁbrosis by enhancing
HSC activation and by acting as an anti-apoptotic signal in
these cells.
This study demonstrates that membranous receptors for
Wnt ligands, which are members of the Fz gene family, are ex-
pressed in human HSCs. In particular, at least three diﬀerent
members of Fz (Fz-2, -7, and -10) are expressed in these cells.
However, using the same methodology used for detecting Fz
gene expression, we were unable to detect Wnt gene expression
in these cells (data not shown). In view of the high sensitivity of
RT-PCR, it is likely that HSCs do not secrete Wnt proteins.
However, since hepatocytes are able to produce Wnt proteins
[12], Fz expression in HSCs in this study implies that these cells
are likely to respond to Wnt proteins within the liver.
Wnt proteins have been grouped into two classes, i.e.,
canonical and non-canonical classes. Canonical Wnts (e.g.
Wnt1, Wnt3A and Wnt8) stabilize b-catenin, and thus activate
the transcriptions of TCF/LEF target genes, whereas non-
canonical Wnts (e.g., Wnt4, Wnt5A and Wnt11) activate othersignaling pathways, such as the planar-cell-polarity-like path-
way and the Wnt/Ca2+ pathway [13]. In addition, the extracel-
lular antagonists of Wnt signaling pathway are classiﬁed into
two groups, i.e., the sFRP and the Dickkopf family [8]. In this
study, we used an sFRP1-overexpressing system to inhibit Wnt
signaling, since sFRP1 has previously been shown to play a
prominent role in the regulation of cellular apoptosis, diﬀeren-
tiation and angiogenesis in many tissues [4,8]. Moreover, our
ﬁndings demonstrate that TCF/LEF-dependent transcriptional
activity was increased in HSCs treated with Wnt3A, and that
this transcriptional activity was signiﬁcantly reduced in sFRP1
over-expressing cells. These observations, therefore, indicate
that canonical Wnt signaling is active in HSCs, and that
sFRP1 functions as a canonical Wnt antagonist in these cells.
Moreover, the activation of canonical Wnt signaling in this
study resulted in HSC activation, which led to increased colla-
gen a1 and a-smooth muscle actin expression. In addition, our
study demonstrated that Wnt signal activation attenuated
HSC apoptosis. Thus these results collectively suggest that
canonical Wnt signaling is active in HSCs and that it partici-
pates in hepatic ﬁbrosis by enhancing HSC activation and sur-
vival.
It has been argued that sFRP1 is likely to be a biphasic mod-
ulator of Wnt signaling [14]. However, sFRP1 over-expression
in this study eﬃciently perturbed canonical Wnt signal-depen-
dent HSC activation. In addition, sFRP1 over-expression in
the present study enhanced TRAIL-induced HSC apoptosis.
In activated HSCs, TRAIL induces apoptosis by activating
TRAIL receptor-dependent pro-apoptotic signals [3]. We ob-
served that TRAIL-induced caspase 8, cytochrome c, and cas-
pase 9 modulations were similar in control and sFRP1-over-
expressing cells, whereas caspase 3 activation was signiﬁcantly
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cytoplasmic proteins are critically involved in the regulation of
the cytochrome c/Apaf-1 caspase activating pathway. Inhibi-
tors of apoptosis proteins (IAPs) including XIAP have been
shown to bind procaspase 9, preventing its activation, and to
bind directly with and inhibit active caspase 9 [15]. Therefore,
it is likely that complex formation between IAPs and caspase 9
might be modulated in sFRP1 over-expressing cells. Indeed,
the present study demonstrates that this complex formation
between XIAP and caspase 9 was diminished in these cells.
In particular, active caspase 9 (37, 35 KD) binding with XIAP
was reduced in these cells (Fig. 4c). This observation suggests
that more active caspase 9 can act on procaspase 3 in these
cells, and that this enhances caspase 3 activation. Therefore,
these ﬁndings indicate that canonical Wnt signaling exerts an
anti-apoptotic eﬀect in HSCs by regulating complex formation
between XIAP and caspase 9.
In conclusion, our results demonstrate that canonical Wnt
signaling is active in HSCs and that it participates in hepatic
ﬁbrosis by promoting HSC activation and survival. Moreover,
since this process was eﬀectively prevented by forced sFRP1
expression, the interruption of canonical Wnt signals may ther-
apeutically be useful as an anti-ﬁbrotic strategy in the liver.
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